Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2010 2
2014 7
2015 6
2016 4
2017 2
2018 9
2019 16
2020 12
2021 8
2022 18
2023 14
2024 19
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial.
Schwenke JM, Schmitt AM, McLennan S, Janiaud P, Läubli H, Binder M, Alborelli I, Matter MS, Hinke J, Widmer CC, Hemkens LG, Kasenda B, Briel M. Schwenke JM, et al. Among authors: laubli h. BMJ Open. 2025 Oct 28;15(10):e100537. doi: 10.1136/bmjopen-2025-100537. BMJ Open. 2025. PMID: 41151945 Free PMC article.
CAR T cell engineering impacts antigen-independent activation and co-inhibition.
Schultheiß C, Stücheli S, Besemer B, Kadel M, Schmidt-Barbo P, Zingg A, Franz N, Adamo S, Stenner F, Fischer C, Läubli H, Binder M. Schultheiß C, et al. Among authors: laubli h. Mol Ther Methods Clin Dev. 2025 Sep 3;33(4):101586. doi: 10.1016/j.omtm.2025.101586. eCollection 2025 Dec 11. Mol Ther Methods Clin Dev. 2025. PMID: 41020262 Free PMC article.
IGLV3-21R110-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia.
Fischer C, Chen SS, Nimmerfroh J, Eugster A, Stücheli S, Schultheiß C, Widmer C, Heim D, Kasenda B, Passweg J, Kobold S, Egli L, Coianiz N, Chijioke O, Chiorazzi N, Follo M, Läubli H, Peipp M, Binder M. Fischer C, et al. Among authors: laubli h. Haematologica. 2025 Sep 11. doi: 10.3324/haematol.2025.287697. Online ahead of print. Haematologica. 2025. PMID: 40931870 Free article.
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma.
Lopez JS, Haefliger S, Plummer R, Clement PM, Jeffry Evans TR, Läubli H, Roth P, Kristeleit R, Brazil L, Tabatabai G, Wick A, Wunderlich B, Beebe K, Eisner JR, Lane H, Engelhardt M, Kaindl T, Hau P, Hundsberger T, Steinbach J. Lopez JS, et al. Among authors: laubli h. Cell Rep Med. 2025 Jun 17;6(6):102165. doi: 10.1016/j.xcrm.2025.102165. Cell Rep Med. 2025. PMID: 40532659 Free PMC article. Clinical Trial.
Dietary intake of the red meat-derived glycan Neu5Gc fuels colorectal cancer through up-regulation of Wnt signaling pathway.
Lopes AL, Paulino AC, Thaumaturgo MAS, Araújo WM, Caloba P, Kawanishi K, Willert K, De Oliveira RP, Machado JC, Lemos F, Varki N, Morgado-Diaz JA, Läubli H, Todeschini AR, Varki A, Alisson-Silva F. Lopes AL, et al. Among authors: laubli h. Cancer Lett. 2025 Apr 28;616:217598. doi: 10.1016/j.canlet.2025.217598. Epub 2025 Feb 27. Cancer Lett. 2025. PMID: 40023392
119 results